Online citations, reference lists, and bibliographies.
← Back to Search

American College Of Chest Physicians And Society Of Thoracic Surgeons Consensus Statement For Evaluation And Management For High-risk Patients With Stage I Non-small Cell Lung Cancer.

J. Donington, M. Ferguson, P. Mazzone, J. Handy, M. Schuchert, H. Fernando, B. Loo, M. Lanuti, A. D. de Hoyos, F. Detterbeck, A. Pennathur, J. Howington, R. Landreneau, G. Silvestri
Published 2012 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
BACKGROUND The standard treatment of stage I non-small cell lung cancer (NSCLC) is lobectomy with systematic mediastinal lymph node evaluation. Unfortunately, up to 25% of patients with stage I NSCLC are not candidates for lobectomy because of severe medical comorbidity. METHODS A panel of experts was convened through the Thoracic Oncology Network of the American College of Chest Physicians and the Workforce on Evidence-Based Surgery of the Society of Thoracic Surgeons. Following a literature review, the panel developed 13 suggestions for evaluation and treatment through iterative discussion and debate until unanimous agreement was achieved. RESULTS Pretreatment evaluation should focus primarily on measures of cardiopulmonary physiology, as respiratory failure represents the greatest interventional risk. Alternative treatment options to lobectomy for high-risk patients include sublobar resection with or without brachytherapy, stereotactic body radiation therapy, and radiofrequency ablation. Each is associated with decreased procedural morbidity and mortality but increased risk for involved lobe and regional recurrence compared with lobectomy, but direct comparisons between modalities are lacking. CONCLUSIONS Therapeutic options for the treatment of high-risk patients are evolving quickly. Improved radiographic staging and the diagnosis of smaller and more indolent tumors push the risk-benefit decision toward parenchymal-sparing or nonoperative therapies in high-risk patients. Unbiased assessment of treatment options requires uniform reporting of treatment populations and outcomes in clinical series, which has been lacking to date.
This paper references
10.1016/j.jtcvs.2011.07.051
Thirty- and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study.
H. Fernando (2011)
10.1016/j.jtcvs.2009.05.045
Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity.
M. Ferguson (2009)
10.1016/J.EJCTS.2006.01.014
Carbon monoxide lung diffusion capacity improves risk stratification in patients without airflow limitation: evidence for systematic measurement before lung resection.
A. Brunelli (2006)
10.1378/CHEST.103.4.1306
Utilization of the peak expiratory flow rate in evaluation of acute dyspnea of cardiac or pulmonary origin.
C. Pollack (1993)
10.1016/j.athoracsur.2009.02.097
Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly.
A. Kilic (2009)
10.1016/S0003-4975(03)01511-X
Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study.
N. Sawabata (2004)
Stereotactic body radiotherapy in treating patients with inoperable stage I or stage II non - small cell lung cancer
JP Grutters
10.1378/CHEST.62.6.694
Prediction of pulmonary function loss due to pneumonectomy using 133 Xe-radiospirometry.
S. Kristersson (1972)
10.1183/09031936.50184308
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) (European Respiratory Journal (2009) 34 (17-41))
A. Brunelli (2009)
Stereotactic body radiotherapy in treating patients with inoperable stage I or stage II non-small cell lung cancer
Rd Timmerman
10.1016/J.IJROBP.2006.04.013
Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.
T. Xia (2006)
10.1016/J.ATHORACSUR.2004.01.024
Segmental resection spares pulmonary function in patients with stage I lung cancer.
R. Keenan (2004)
10.1016/j.ejcts.2008.07.037
Modeling major lung resection outcomes using classification trees and multiple imputation techniques.
M. Ferguson (2008)
10.1016/j.athoracsur.2008.03.025
Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection.
A. Brunelli (2008)
10.1016/J.EJCTS.2006.08.015
Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors.
L. Thanos (2006)
10.1183/09031936.96.09030415
Pulmonary function and exercise capacity after lung resection.
C. Bolliger (1996)
10.1097/01.anes.0000296072.02527.18
Type and Severity of Cognitive Decline in Older Adults after Noncardiac Surgery
C. Price (2008)
A casematched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high - risk patients
AE Martin-Ucar (2005)
10.1016/0003-4975(95)00537-U
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.
R. Ginsberg (1995)
10.1016/0003-4975(96)00087-2
Preoperative assessment of the high-risk patient for lung resection.
P. Pate (1996)
Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation.
S. Singh (1994)
Phase III randomised study of lobectomy versus sublobar resection in patients with small peripheral stage IA non - small cell lung cancer
NK Altorki
10.1186/1749-8090-4-41
UK pneumonectomy outcome study (UKPOS): a prospective observational study of pneumonectomy outcome
E. Powell (2009)
10.1378/CHEST.102.6.1774
Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection.
D. Holden (1992)
10.1016/S1072-7515(02)01228-0
Is surgery getting safer? National trends in operative mortality.
P. Goodney (2002)
10.1002/JSO.10145
Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis
H. Kawasaki (2002)
Radiofrequency ablation for treatment of medically inoperable stage I nonsmall cell lung cancer
M Lanuti (2009)
Thirtyand ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: results from a multicenter phase III study
Hc Fernando (2011)
10.1016/j.lungcan.2009.05.007
Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
U. Ricardi (2010)
10.1080/02841860600904862
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
P. Baumann (2006)
10.1097/JTO.0B013E318074DE1B
A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer.
M. Hiraoka (2007)
10.1378/CHEST.114.4.1112
Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer.
T. d’Amato (1998)
10.1378/CHEST.120.1.3
Cryotherapy in early lung cancer.
R. Thurer (2001)
10.1016/S0022-5223(12)70385-9
Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. Five-year survival and patterns of intrathoracic recurrence.
W. Warren (1994)
Evidence-based guideline development process American College of Chest Physicians website. http :// www . chestnet . org / accp / guidelines / development -process
(2012)
10.1097/01.RVI.0000228373.58498.6E
Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.
C. Grieco (2006)
10.1378/CHEST.128.1.237
Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.
C. Mery (2005)
10.1001/jama.2010.261
Stereotactic body radiation therapy for inoperable early stage lung cancer.
R. Timmerman (2010)
10.1016/J.ATHORACSUR.2006.11.062
Predicted versus observed FEV1 and DLCO after major lung resection: a prospective evaluation at different postoperative periods.
A. Brunelli (2007)
10.1016/j.jtcvs.2009.08.026
Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.
S. Paul (2010)
10.1016/j.jtcvs.2009.11.059
Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial.
W. Scott (2010)
10.1378/CHEST.125.5.1735
Actual and predicted postoperative changes in lung function after pneumonectomy: a retrospective analysis.
S. A. Smulders (2004)
10.1097/RTI.0b013e3181e48d5e
Percutaneous Radiofrequency Ablation of Lung Tumors: Evaluation of the Literature Using Evidence-based Techniques
V. Chan (2011)
10.1055/S-2007-965406
Comparison between a case-matched analysis of left upper lobe trisegmentectomy and left upper lobectomy for small size lung cancer located in the upper division.
A. Iwasaki (2007)
Video - assisted thoracic surgery versus open lobectomy for lung cancer : a secondary analysis of data from the American College of Surgeons Oncology Group Z 0030 randomized clinical trial
WJ Scott (2007)
10.1016/J.EJCTS.2005.01.006
A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients.
A. Martin-Ucar (2005)
10.1016/J.ATHORACSUR.2005.06.066
Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial.
M. Allen (2006)
10.1016/j.athoracsur.2009.04.015
Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
Robert J. Cerfolio (2009)
10.1586/era.09.117
Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy
Jeffrey A. Forquer (2009)
10.1016/j.ijrobp.2008.10.067
Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
M. Campeau (2009)
The role of radiotherapy in treatment of stage I non - small cell
X Qiao (2003)
10.1111/j.1440-1843.2005.00759.x
Pulmonary artery pressure and blood flow as predictors of outcome from lung cancer resection
R. Pierce (2005)
10.1016/J.JTCVS.2004.09.025
Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
H. Fernando (2005)
10.1016/j.jtcvs.2010.10.061
The impact of adjuvant brachytherapy with sublobar resection on pulmonary function and dyspnea in high-risk patients with operable disease: preliminary results from the American College of Surgeons Oncology Group Z4032 trial.
H. Fernando (2011)
10.1016/J.AMJSURG.2006.08.019
Determinants of quality of life in patients following pulmonary resection for lung cancer.
D. Paull (2006)
Pri - mary non - small cell lung cancer : review of frequency , location , and time of recurrence after radiofrequency ablation
CA Grieco (2010)
10.1378/CHEST.90.2.222
Uncertainties in the expected value for forced expiratory volume in one second after surgery.
M. L. Ladurie (1986)
10.1067/MTC.2003.156
Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer.
T. Koike (2003)
10.1016/S0169-5002(03)00152-1
The role of radiotherapy in treatment of stage I non-small cell lung cancer.
X. Qiao (2003)
10.1016/J.ATHORACSUR.2005.08.052
Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.
T. Birdas (2006)
10.1016/0003-4975(94)90731-5
Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption.
G. Walsh (1994)
Lobar and sub - lobar resection with and without brachytherapy for small stage IA non - small cell lung cancer
HC Fernando (2005)
10.1007/s00270-005-0187-9
Usefulness of Guiding Needles for Radiofrequency Ablative Treatment of Liver Tumors
T. Baère (2005)
10.1136/thorax.56.10.791
Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema
J. Edwards (2001)
Pulmonary radiofrequency ablation--an international study survey.
K. Steinke (2004)
10.1016/J.EJCTS.2005.08.001
Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection.
A. Bobbio (2005)
Anatomic seg - mentectomy in the treatment of stage I non - small cell lung cancer
MJ Schuchert
10.1378/CHEST.99.3.587
Stair climbing as an exercise test to predict the postoperative complications of lung resection. Two years' experience.
G. Olsen (1991)
Surgery with or without internal radiation therapy in treating patients with stage I non-small cell lung cancer. ACOSOG Z4032. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health
Hc Fernando
Lung Cancer Study Group Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
Rj Ginsberg (1995)
10.1016/j.athoracsur.2009.08.055
The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005.
P. Schipper (2009)
10.1016/J.RADONC.2007.10.017
A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer.
M. Koto (2007)
Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-smallcell lung cancer
Ca Grieco (2006)
10.1378/CHEST.06-3096
Natural history of stage I non-small cell lung cancer: implications for early detection.
D. Raz (2007)
10.1016/J.EJCTS.2007.07.014
A model to predict the immediate postoperative FEV1 following major lung resections.
A. Brunelli (2007)
10.1016/j.ijrobp.2008.08.036
Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?
B. Hoppe (2008)
10.1016/j.jtcvs.2007.07.060
Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors.
D. Boffa (2008)
Thirty - and ninetyday outcomes after sublobar resection with and without brachytherapy for non - small cell lung cancer : results from a multicenter phase III study
HC Fernando (2011)
Defi nitive treatment of poor-risk patients with stage I lung cancer: a single institution experience
M Hsie (2009)
10.1016/j.ijrobp.2009.12.022
Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
Y. Matsuo (2011)
10.1016/S0022-5223(98)70444-1
Thirty-day operative mortality for thoracotomy in lung cancer.
H. Wada (1998)
10.1016/J.ATHORACSUR.2005.06.010
Functional advantage after radical segmentectomy versus lobectomy for lung cancer.
H. Harada (2005)
10.1080/02841860600812685
Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors
Sang Min Yoon (2006)
10.1016/S0022-5223(19)40590-4
Segmental resection for lung cancer. A fifteen-year experience.
R. Jensik (1973)
Surgery with or without internal radiation therapy in treating patients with stage I non - small cell lung cancer
HC Fernando
10.1245/s10434-008-0025-9
Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients
M. Cheung (2008)
10.1016/j.athoracsur.2007.11.063
Radiofrequency ablation to treat non-small cell lung cancer and pulmonary metastases.
H. Fernando (2008)
10.1200/JCO.2009.25.0753
Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.
J. Bogart (2010)
Phase III randomised study of lobectomy versus sublobar resection in patients with small peripheral stage IA non-small cell lung cancer. CALGB-140503
Nk Altorki
10.1016/J.JTCVS.2004.04.030
Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
M. Okada (2005)
10.1016/J.IJROBP.2006.04.015
Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
L. Fang (2006)
Morbidity and mortality of major pulmonary resections in patients with early - stage lung cancer : initial results of the randomized , prospective ACOSOG Z 0030 trial
MS Allen (2006)
Surgery with or without internal radiation therapy compared with stereotactic body radiation therapy in treating patients with high - risk stage I non - small cell lung cancer
Beland
10.1378/CHEST.111.6.1542
Perfusion lung scintigraphy for the prediction of postlobectomy residual pulmonary function.
A. Giordano (1997)
" Pulmonary radiofrequency ablationinternational study survey
K. Steinke (2004)
Stereotactic body radiation therapy for early stage non - small
U Ricardi
10.2214/AJR.10.6108
Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
D. Yoo (2011)
10.1016/0003-4975(95)00481-Y
Exercise oximetry versus spirometry in the assessment of risk prior to lung resection.
V. Rao (1995)
Pulmonary artery pressure and blood fl ow as predictors of outcome from lung cancer resection
RJ Pierce (2008)
Radiofrequency ablation in treating patients with stage I non - small cell lung cancer
D Dupuy
10.1016/S0022-5223(19)39174-3
Prediction of postoperative pulmonary function following thoracic operations. Value of ventilation-perfusion scanning.
W. Bria (1983)
10.1016/J.IJROBP.2005.06.029
Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
M. Chen (2006)
10.1016/S0022-5223(97)70226-5
Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.
R. Landreneau (1997)
10.1378/CHEST.101.2.356
Exercise testing in the evaluation of patients at high risk for complications from lung resection.
R. Morice (1992)
Surgery with or without internal radiation therapy compared with stereotactic body radiation therapy in treating patients with high-risk stage I non-small cell lung cancer
H Fernando
10.1016/j.radonc.2009.08.003
Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis.
J. Grutters (2010)
10.1097/JTO.0b013e318074de34
Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study
H. Onishi (2007)
Radiofrequency ablation of medically inoperable stage IA non - small cell lung cancer : does early post treatment positron emission tomography predict treatment outcome
DC Yoo (2011)
10.1016/j.ijrobp.2008.11.042
Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.
A. Fakiris (2009)
10.1016/j.athoracsur.2008.03.063
A scoring system predicting the risk for intensive care unit admission for complications after major lung resection: a multicenter analysis.
A. Brunelli (2008)
10.1016/j.radonc.2009.03.022
Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
N. Pettersson (2009)
10.1148/radiol.2473070996
Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients.
Farrah J. Wolf (2008)
Thoracic Surgery Study Group of Osaka University . Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study
N Sawabata (2004)
10.1016/J.IJROBP.2010.07.104
A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer: Japan Clinical Oncology Group (JCOG0403)
Y. Nagata (2010)
10.1016/S1470-2045(08)70155-4
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).
R. Lencioni (2008)
10.1183/09031936.00184308
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
A. Brunelli (2009)
10.1016/j.jtcvs.2008.08.034
Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.
M. Lanuti (2009)
10.1148/RADIOL.2402050807
Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation.
T. de Baère (2006)
10.1378/CHEST.116.SUPPL_3.477S
Treatment of patients with lung cancer and severe emphysema.
S. Mentzer (1999)
10.1055/S-2005-865682
Prediction of morbidity after lung resection in patients with lung cancer using fuzzy logic.
A. Turna (2005)
10.1378/CHEST.108.1.68
Predicting postoperative pulmonary function in patients undergoing lung resection.
B. Zeiher (1995)
Ran - domized trial of lobectomy versus limited resection for T 1 N 0 non - small cell lung cancer
RJ Ginsberg (1995)
using a novel irradiation technique : patient selfcontrolled breathhold and beam switching using a combination of linear accelerator and CT scanner
S. Paul
Ann Thorac Surg
(1997)
10.1378/CHEST.111.6.1710
Revisions in the International System for Staging Lung Cancer.
C. Mountain (1997)
10.1097/JTO.0b013e318074bba7
Preoperative Exercise Vo2 Measurement for Lung Resection Candidates: Results of Cancer and Leukemia Group B Protocol 9238
G. Loewen (2007)
10.1016/J.JTCVS.2007.07.013
Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
T. Hiraki (2007)
10.1016/S1010-7940(02)00122-7
A new method of segmental resection for primary lung cancer: intermediate results.
T. Bando (2002)
10.1016/J.IJROBP.2007.06.043
Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
R. Onimaru (2008)
10.1016/j.athoracsur.2008.03.024
Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model.
C. Wright (2008)
10.1016/1010-7940(94)90013-2
Lung cancer surgery in the octogenarian.
K. Naunheim (1994)
10.2214/AJR.183.4.1831003
CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer--a preliminary report of 33 patients.
G. Belfiore (2004)
10.1016/j.athoracsur.2007.12.071
Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease.
M. Ferguson (2008)
Stereotactic body radiation therapy in treating patients with stage I non - small cell lung cancer . RTOG 0618 . ClinicalTrials . gov . Bethesda , MD
R Timmerman
Midterm local effi cacy and survival after radiofrequency ablation of lung tumors with minimum follow - up of 1 year : prospective eval
T deBaère (2006)
10.1148/RADIOL.2431060088
Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
Caroline J. Simon (2007)
10.1016/J.LUNGCAN.2004.01.004
Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner.
H. Onishi (2004)
10.1016/j.athoracsur.2009.04.035
Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study.
D. Mason (2009)
Comparison between sublobar resection and 125 Iodine brachytherapy after sublobar resection in high - risk patients with Stage I non - small -
R Santos (2003)
The role of radiotherapy in treatment of stage I non - small
X Qiao (2003)
10.1148/RADIOL.2301020934
Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.
Jeong Min Lee (2004)
10.1378/chest.08-1114
The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non-small cell lung cancer.
T. Schulte (2009)
10.1016/S1556-0864(15)30409-3
Results of a Phase I Dose-Escalation Study Using Single-Fraction Stereotactic Radiotherapy for Lung Tumors
Q. Le (2006)
10.1016/j.ijrobp.2009.02.027
Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
N. Dunlap (2010)
10.1016/S1556-0864(15)30408-1
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated Radiotherapy
P. Graham (2006)
10.1245/s10434-007-9421-9
Margin and Local Recurrence After Sublobar Resection of Non-Small Cell Lung Cancer
A. El-Sherif (2007)
10.1007/S12094-009-0307-0
Radiofrequency thermocoagulation of lung tumours. Where we are, where we are headed
Fernando M. Gómez (2009)
10.1016/J.EJCTS.2005.03.047
The European Thoracic Surgery Database project: modelling the risk of in-hospital death following lung resection.
R. Berrisford (2005)
10.2482/HAIGAN.40.261
Surgical treatment of lung cancer in the octogenarian.
T. Osaki (1994)
10.1016/j.athoracsur.2009.12.065
Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy.
M. Berry (2010)
10.1378/CHEST.122.1.21
What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery.
J. Handy (2002)
10.1016/S0003-4975(03)00340-0
Peripheral lung adenocarcinomas: 10 mm or less in diameter.
D. Kondo (2003)
10.1378/CHEST.121.4.1155
Observation-only management of early stage, medically inoperable lung cancer: poor outcome.
R. Mcgarry (2002)
10.1016/S0039-6060(03)00327-1
Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer.
R. Santos (2003)
10.1016/J.IJROBP.2005.03.073
Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study.
R. Mcgarry (2005)
vival analysis of untreated patients with non - small - cell lung cancer
E Vrdoljak (1994)
10.1016/S0003-4975(10)62591-X
A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer.
K. Nakahara (1985)
10.1016/j.athoracsur.2008.12.030
Surgeon specialty and long-term survival after pulmonary resection for lung cancer.
F. Farjah (2009)
10.1159/000066474
Prediction of Functional Reserves after Lung Resection: Comparison between Quantitative Computed Tomography, Scintigraphy, and Anatomy
C. Bolliger (2002)
10.1016/S0003-4975(02)04098-5
Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds.
W. Lee (2003)
10.1097/JTO.0b013e3181622c17
Prevalence of Poor Performance Status in Lung Cancer Patients: Implications for Research
R. Lilenbaum (2008)
10.1186/1748-717X-2-39
Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors
B. Collins (2007)
10.1016/J.THORSURG.2007.07.008
Predictive ability of preoperative indices for major pulmonary surgery.
A. Brunelli (2007)
10.1016/j.jtcvs.2009.03.030
Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer.
R. Flores (2009)
10.1016/j.ijrobp.2007.12.051
Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.
M. Henderson (2008)
10.1056/NEJMSA012528
Understanding the treatment preferences of seriously ill patients.
T. Fried (2002)
A phase II study on stereotactic body radiotherapy for stage I non - small cell lung can
M Koto
10.1200/JCO.2006.07.5937
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.
R. Timmerman (2006)
10.1002/cncr.22541
Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies
Y. Sano (2007)
10.1510/icvts.2008.178947
Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
T. Chamogeorgakis (2009)
10.1378/chest.08-2059
Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection.
A. Brunelli (2009)
10.1016/j.athoracsur.2007.09.046
Are surgical outcomes for lung cancer resections improved at teaching hospitals?
R. Meguid (2008)
10.1378/CHEST.129.3.738
Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.
D. Dupuy (2006)
10.1016/0003-4975(96)85176-9
Lobectomy versus limited resection in T1 N0 lung cancer.
F. Lederle (1996)
10.1016/j.ejcts.2009.05.011
Prospective population-based study comparing quality of life after pneumonectomy and lobectomy.
U. Sartipy (2009)
10.1097/JTO.0b013e3181914d3a
Definitive Treatment of Poor-Risk Patients with Stage I Lung Cancer: A Single Institution Experience
M. Hsie (2009)
10.1016/S0003-4975(99)00992-3
Cognitive decline after major noncardiac operations: a preliminary prospective study.
K. Grichnik (1999)
10.1016/S0022-5223(03)00028-X
Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection.
P. Kumar (2003)
10.1016/j.jtcvs.2008.07.016
Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?
A. Watanabe (2008)
10.1378/CHEST.07-1359
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition).
G. Colice (2007)
10.1378/CHEST.106.6.1797
Survival analysis of untreated patients with non-small-cell lung cancer.
E. Vrdoljak (1994)
10.1200/JCO.2008.21.5681
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
P. Baumann (2009)
Anatomic seg - mentectomy for stage I non - small cell lung cancer in the elderly
A Kilic
10.1016/S1040-1741(08)79080-8
Pulmonary Radiofrequency Ablation: Long-term Safety and Efficacy in 153 Patients
E. Glatstein (2008)
10.1148/RADIOL.2351030747
Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures.
H. Wang (2005)
10.1016/j.ijrobp.2009.04.080
Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer.
Noëlle C van der Voort van Zyp (2010)
10.1016/S0022-5223(19)39080-4
Modern thirty-day operative mortality for surgical resections in lung cancer.
R. Ginsberg (1983)
10.1016/J.JTCVS.2004.10.019
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
H. Fernando (2005)
10.1378/CHEST.77.3.337
Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma.
M. K. Ali (1980)
10.1148/radiol.2541090174
Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
M. Beland (2010)
10.1016/J.JTCVS.2006.02.063
Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study.
M. Okada (2006)
10.1016/j.athoracsur.2008.11.017
Radiofrequency ablation of lung tumors: feasibility and safety.
J. C. Zhu (2009)
10.1378/CHEST.128.3.1461
Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer.
J. Wisnivesky (2005)
10.1016/J.JTCVS.2007.04.060
Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
A. Pennathur (2007)
10.1016/j.ejcts.2008.07.028
Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery.
M. Chida (2008)
10.1016/j.athoracsur.2009.09.086
Radiofrequency ablation in the lung complicated by positive airway pressure ventilation.
A. Nachiappan (2010)
10.1016/J.ATHORACSUR.2007.03.013
Evidence of lower alteration of expiratory volume in patients with airflow limitation in the immediate period after lobectomy.
G. Varela (2007)
10.1016/J.EJCTS.2006.07.001
Predicted versus observed FEV1 in the immediate postoperative period after pulmonary lobectomy.
G. Varela (2006)
10.1002/cncr.10853
Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas
S. Fukumoto (2002)
: results of a prospective trial
T Xia (2010)
A phase II trial of stereotactic body radiation therapy for operable T 1 N 0 M 0 non - small
H. M. Nagata Y (2010)
10.1213/ANE.0b013e3181bf5c99
A Clinical Prediction Rule for Pulmonary Complications After Thoracic Surgery for Primary Lung Cancer
D. Amar (2010)
10.1200/JCO.2013.31.15_SUPPL.7523
RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients.
R. Timmerman (2013)
10.1016/J.ATHORACSUR.2007.05.007
Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.
M. Schuchert (2007)
10.1378/CHEST.113.6.1511
Recovery and limitation of exercise capacity after lung resection for lung cancer.
K. Nezu (1998)
10.1245/s10434-008-9848-7
A Systematic Review of Radiofrequency Ablation for Lung Tumors
J. C. Zhu (2008)
mary non - small cell lung cancer : review of frequency , location , and time of recurrence after radiofrequency ablation
CA Grieco (2010)
10.1164/AJRCCM.150.4.7921468
Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality.
R. Pierce (1994)
10.1001/ARCHINTE.1996.00440060067008
Functional outcomes of acute medical illness and hospitalization in older persons.
M. Sager (1996)
10.1016/s0012-3692(15)52923-1
Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study.
C. L. Nguyen (2005)
10.1016/J.ATHORACSUR.2005.06.071
Patterns of surgical care of lung cancer patients.
A. Little (2005)
10.1136/thx.42.4.285
Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy.
P. Corris (1987)
10.1097/01.sla.0000149428.17238.03
Surgeon Specialty and Operative Mortality With Lung Resection
P. Goodney (2005)
10.1016/J.JTCVS.2004.05.011
Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study.
H. Shennib (2005)
10.1111/j.1532-5415.1999.tb03002.x
Risk Factors for Lack of Recovery of ADL Independence After Hospital Discharge
K. Hansen (1999)
Stereotactic body radiation therapy in treating patients with stage I non-small cell lung cancer
R Timmerman
10.1016/S0003-4975(97)00474-8
Standardized exercise oximetry predicts postpneumonectomy outcome.
M. Ninan (1997)
domized trial of lobectomy versus limited resection for T 1 N 0 non - small cell lung cancer
RJ Ginsberg (1995)



This paper is referenced by
10.1016/j.thorsurg.2011.08.018
Management of early stage non-small cell lung cancer in high-risk patients.
J. Donington (2012)
10.1016/j.jvir.2013.04.021
Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete?
D. Dupuy (2013)
10.1097/PAS.0000000000000872
Tumor Spread Through Air Spaces Is an Independent Predictor of Recurrence-free Survival in Patients With Resected Lung Squamous Cell Carcinoma
Kyuichi Kadota (2017)
10.1155/2014/152087
Radiofrequency Ablation for Early-Stage Nonsmall Cell Lung Cancer
T. Hiraki (2014)
10.1053/j.seminoncol.2013.12.011
Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy.
S. Padda (2014)
10.1007/978-981-15-3734-9
Chronic Lung Diseases: Pathophysiology and Therapeutics
Sheikh Rayees (2020)
10.1093/icvts/ivv389
Is there a role for the high-risk multidisciplinary team meeting in thoracic surgery?
N. Nwaejike (2016)
Name of Blue Advantage Policy: Radiofrequency Ablation of Solid Tumors Excluding Liver Tumors
(2018)
10.1093/icvts/ivz116
Spread through air spaces is an independent predictor of recurrence in stage III (N2) lung adenocarcinoma.
Y. Terada (2019)
10.1016/j.jtho.2017.09.1956
Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies
M. Meyer (2017)
10.1186/s12931-018-0948-z
Investigating the mechanism by which SMAD3 induces PAX6 transcription to promote the development of non-small cell lung cancer
Zhe Qian (2018)
10.7785/tcrt.2012.500445
Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis
H. Bahig (2015)
10.1016/j.ijrobp.2018.01.050
A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.
T. Shintani (2018)
10.1186/s13014-020-1479-6
Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
Jeffrey M Ryckman (2020)
10.1016/j.cllc.2013.08.007
Stereotactic body radiation therapy in octogenarians with stage I lung cancer.
A. Sandhu (2014)
10.1200/JCO.2014.60.6624
Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology.
R. Veluswamy (2015)
10.1016/J.RXENG.2014.12.002
Pulmonary radiofrequency ablation (Part 1): Current state
J. Martinez (2015)
10.1016/j.jtcvs.2018.09.107
The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.
M. Guckenberger (2019)
10.1007/s00330-020-07634-7
Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
M. Chan (2021)
10.1016/j.prro.2016.01.009
Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease.
H. Bahig (2016)
10.1016/j.jvir.2013.05.068
Editor's suggested readings in interventional oncology.
Z. Haskal (2013)
10.1016/j.jtho.2018.06.007
Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy
Kevin Shiue (2018)
10.1111/resp.13903
Bronchoscopic treatments for early-stage peripheral lung cancer: Are we ready for prime time?
Daniel P Steinfort (2020)
10.1097/COC.0000000000000013
ACR Appropriateness Criteria® Early-Stage Non–Small–Cell Lung Cancer
G. Videtic (2014)
Implementación de radioterapia estereotáxica torácica en un hospital terciario: resultados preliminares
María del Pino Alcántara Carrió (2017)
10.1513/AnnalsATS.201305-117OC
Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%).
S. Paul (2013)
Radiofrequency Tumor Ablation
(2019)
10.5152/balkanmedj.2015.15553
Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?
Esengül Koçak Uzel (2015)
10.21037/JTD-20-2253
Salvage surgery to treat tumor regrowth after stereotactic body radiotherapy in primary non-small cell lung cancer.
Takahisa Koizumi (2020)
10.1007/s10147-014-0741-z
Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller
Satoru Ochiai (2014)
10.3978/j.issn.2072-1439.2013.11.09
New techniques for assessing response after hypofractionated radiotherapy for lung cancer.
Sarah A. Mattonen (2014)
10.1101/518910
Determinants of Cancer-specific Quality of Life in Veteran Lung Cancer Survivors Eligible for Long-Term Cure
D. Ha (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar